Covered recipient · General Payments record
TIMOTHY JAMES KAMERZELL
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,143.93
- Reported across 206 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $543.28 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $137.61 | 8 |
| Lilly USA, LLC | $73.88 | 4 |
| Novo Nordisk AS | $66.65 | 4 |
| EISAI INC. | $42.73 | 2 |
| Nevro Corp. | $36.59 | 2 |
| DEXCOM, INC. | $34.89 | 2 |
| Amgen Inc. | $26.62 | 2 |
| Ardelyx, Inc. | $22.68 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $22.21 | 1 |
| Abbott Laboratories | $21.76 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.22 | 1 |
| Mylan Specialty L.P. | $14.21 | 1 |
| GlaxoSmithKline, LLC. | $14.12 | 1 |
| PFIZER INC. | $14.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.76 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125105182 | CMS |
| ABBVIE INC. | $20.58 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104024567 | CMS |
| ABBVIE INC. | $20.65 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104024569 | CMS |
| ABBVIE INC. | $15.81 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104024571 | CMS |
| ABBVIE INC. | $13.81 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104024573 | CMS |
| ABBVIE INC. | $22.93 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104024575 | CMS |
| ABBVIE INC. | $5.07 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104024577 | CMS |
| ABBVIE INC. | $30.95 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104024579 | CMS |
| ABBVIE INC. | $7.81 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104024581 | CMS |
| Amgen Inc. | $13.31 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117593310 | CMS |
| Amgen Inc. | $13.31 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117593312 | CMS |
| Ardelyx, Inc. | $22.68 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146687753 | CMS |
| Boston Scientific Corporation | $22.21 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092579185 | CMS |
| Dexcom, Inc. | $17.22 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153341265 | CMS |
| Dexcom, Inc. | $17.67 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153341267 | CMS |
| Eisai Inc. | $22.16 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785955 | CMS |
| Eisai Inc. | $20.57 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785957 | CMS |
| GlaxoSmithKline, LLC. | $14.12 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116602151 | CMS |
| Lilly USA, LLC | $24.66 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135497576 | CMS |
| Lilly USA, LLC | $15.11 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135458670 | CMS |
| Lilly USA, LLC | $19.46 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135497578 | CMS |
| Lilly USA, LLC | $14.65 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135450292 | CMS |
| Mylan Specialty L.P. | $14.21 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147372782 | CMS |
| Nevro Corp. | $15.07 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130738962 | CMS |
| Nevro Corp. | $21.52 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130738960 | CMS |
| Novo Nordisk Inc | $18.21 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096951620 | CMS |
| Novo Nordisk Inc | $17.35 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096739624 | CMS |
| Novo Nordisk Inc | $15.45 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096566260 | CMS |
| Novo Nordisk Inc | $15.64 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096603859 | CMS |
| PFIZER INC. | $14.11 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132106194 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.22 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153492003 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.